QA: Tonix Pharmaceuticals Holding Corp in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001430306_2023_Tonix_Pharmaceuticals_Holding_Corp.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001430306, Tonix Pharmaceuticals Holding Corp

  xvar xval
0 AssetsCurrent 130,777,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 93,814,000
3 remainder_Assets 1,099,000
4 LiabilitiesCurrent 18,180,000
5 LiabilitiesNoncurrent 328,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 45,017,223
9 ResearchAndDevelopmentExpense 98,218,580
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 913,279
13 remainder_ComprehensiveNetIncome -65,042
  yvar yval
0 Assets 225,690,000
1 Liabilities 18,508,000
2 Expenses 143,235,803
3 Revenues 0
4 StockholdersEquity 207,182,000
5 NetIncome -142,322,524
6 ComprehensiveNetIncome -142,355,045
7 BaseVar 194,206,062
8 EconomicCapitalRatiobeforeLimitedLiability 2.53
9 EconomicCapitalRatio 3.38

Edgar->Model Mapping

Feature Distribution

Change over Time